losartan has been researched along with xe 991, anthracenone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alenina, N; Anistan, YM; Bader, M; Gollasch, M; Heidenreich, M; Hercule, HC; Jentsch, TJ; Kassmann, M; Pathan, AR; Rusch, NJ; Schleifenbaum, J; Szijártó, IA; Tano, JY; Weinert, S | 1 |
1 other study(ies) available for losartan and xe 991, anthracenone
Article | Year |
---|---|
Stretch-activation of angiotensin II type 1a receptors contributes to the myogenic response of mouse mesenteric and renal arteries.
Topics: 4-Aminopyridine; Angiotensin II Type 1 Receptor Blockers; Animals; Anthracenes; GTP-Binding Protein alpha Subunits, Gq-G11; HEK293 Cells; Hemorheology; Humans; KCNQ Potassium Channels; KCNQ3 Potassium Channel; Losartan; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Smooth Muscle; Osmotic Pressure; Pressoreceptors; Receptor, Angiotensin, Type 1; Renal Artery; Transcription, Genetic; TRPC Cation Channels; TRPC6 Cation Channel; Vascular Resistance | 2014 |